X4 Pharmaceuticals
XFOR • NASDAQ
X4 Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Adam R. Craig, with a market cap of $370.0M.
Market Cap$370.0M
Employees93.0
CEOAdam R. Craig
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
X4 Pharmaceuticals FAQ
Common questions about X4 Pharmaceuticals
X4 Pharmaceuticals is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $3.5M.
X4 Pharmaceuticals has approximately 93 employees.